Clever Leaves Holdings Inc.

CLVR Healthcare Drug Manufacturers Specialty & Generic

Clever Leaves Holdings Inc.’s revenue for fiscal 2023 (year ended December 2023) was $17.4 million, up 6.14% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.

0.01 0.00 0.00%
Market cap
$96.5M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−9.41
Beneish M
−3.86
Dividend safety
n/a
Older periods Mar '23 Jun '23 Sep '23 Dec '23
Piotroski F-Score

+8 more TTM periods

5 3 2 3
ROE
(90.77%) (95.59%) (83.94%) (55.39%)
ROA
(62.39%) (76.41%) (69.85%) (42.95%)
ROIC
(81.85%) (81.07%) (46.48%) (52.59%)
Return on Tangible Assets
(201.75%) (236.65%) (174.63%) (87.53%)
Average Days of Receivables
152.83 130.39 78.33 53.56
Free Cash Flow per Share
(17.03) (12.07) (7.52) (5.53)
Free Cash Flow
(24.90) (18.03) (11.87) (8.68)
Other line items

Show all line items

Columns are period end dates